Nevirapine [clinicaltrials_resource:efec8a49f3bae1c2b49921e7cede0b61]
A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children [clinicaltrials:NCT00000634]An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3) [clinicaltrials:NCT00000649]An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3 [clinicaltrials:NCT00000747]A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine [clinicaltrials:NCT00000770]A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3) [clinicaltrials:NCT00000781]A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers [clinicaltrials:NCT00000808]A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease [clinicaltrials:NCT00000814]A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies [clinicaltrials:NCT00000869]Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection [clinicaltrials:NCT00000872]A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection [clinicaltrials:NCT00000895]A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients [clinicaltrials:NCT00000896]A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment [clinicaltrials:NCT00000902]A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART) [clinicaltrials:NCT00000922]A Study to Compare Two Different Anti-HIV Drug Regimens [clinicaltrials:NCT00000924]A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies [clinicaltrials:NCT00000942]The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients [clinicaltrials:NCT00000962]Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease [clinicaltrials:NCT00001045]Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001083]Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens [clinicaltrials:NCT00001091]A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir [clinicaltrials:NCT00001095]A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses [clinicaltrials:NCT00001108]A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children [clinicaltrials:NCT00001111]A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants [clinicaltrials:NCT00001135]A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine [clinicaltrials:NCT00001688]An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease [clinicaltrials:NCT00002166]An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. [clinicaltrials:NCT00002194]A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell [clinicaltrials:NCT00002323]The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease [clinicaltrials:NCT00002324]The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection [clinicaltrials:NCT00002347]The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs [clinicaltrials:NCT00002368]The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine [clinicaltrials:NCT00002381]A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs [clinicaltrials:NCT00002407]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002418]A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors [clinicaltrials:NCT00004580]A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment [clinicaltrials:NCT00004581]Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [clinicaltrials:NCT00004855]The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months [clinicaltrials:NCT00006279]Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns [clinicaltrials:NCT00006396]Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [clinicaltrials:NCT00013520]Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [clinicaltrials:NCT00016601]
intervention [clinicaltrials_vocabulary:intervention]
Nevirapine [clinicaltrials_resource:efec8a49f3bae1c2b49921e7cede0b61]
Bio2RDF identifier
efec8a49f3bae1c2b49921e7cede0b61
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:efec8a49f3bae1c2b49921e7cede0b61
intervention name [clinicaltrials_vocabulary:intervention-name]
Nevirapine
identifier
clinicaltrials_resource:efec8a49f3bae1c2b49921e7cede0b61
title
Nevirapine
@en
type
label
Nevirapine [clinicaltrials_resource:efec8a49f3bae1c2b49921e7cede0b61]
@en